Vale SA
VALE
Microsoft
MSFT
D.R. Horton
DHI
4
Toll Brothers
TOL
5
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
RLMD Relmada Therapeutics
- 0.2860
- +0.0272+10.51%
Close Apr 10 16:00 ET
- 0.2650
- -0.0210-7.34%
Pre 08:55 ET
9.49MMarket Cap-0.11P/E (TTM)
0.2882High0.2624Low274.70KVolume0.2680Open0.2588Pre Close75.95KTurnover0.90%Turnover RatioLossP/E (Static)33.19MShares4.729952wk High0.27P/B8.74MFloat Cap0.240452wk Low--Dividend TTM30.57MShs Float54.0000Historical High--Div YieldTTM9.97%Amplitude0.2404Historical Low0.2760Avg Price1Lot Size
About Relmada Therapeutics Company
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.
Company Profile
SymbolRLMD
Company NameRelmada Therapeutics
Listing DateOct 10, 2019
Issue Price0.00
Founded2012
CEODr. Sergio Traversa
MarketNASDAQ
Employees17
Fiscal Year Ends12-31
Address2222 Ponce de Leon Boulevard,3rd floor
CityCoral Gables
ProvinceFlorida
CountryUnited States of America
Zip Code33134
Phone1-786-629-1376
Websitehttp://www.relmada.com
Company Executives
- Name
- Position
- Salary
- Dr. Sergio Traversa
- Chief Executive Officer and Director
- 4.78M
- Charles S. Ence
- Chief Accounting and Compliance Officer
- 2.33M
- Paul Kelly
- Director and Chief Operating Officer
- 1.67M
- Maged Shenouda
- Chief Financial Officer and Principal Accounting Officer
- 2.34M
- Charles J. Casamento
- Chairman of the Board
- 674.90K
- Fabiana Fedeli
- Independent Director
- 1.33M
- John Glasspool
- Independent Director
- 604.77K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025